MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides Life Science Investing
Profound Medical Honored with INOVAIT's 2025-2026 Mount Logan Award Recognizing the TULSA Procedure for Prostate Disease Life Science Investing
Benitec Biopharma Releases Second Quarter 2026 Financial Results and Provides Operational Update Life Science Investing
Rain Enhancement Technologies Reports More Than 20% Snowpack Enhancement in Utah During January Operations Life Science Investing
Fulgent to Announce Fourth Quarter and Full Year 2025 Financial Results on Friday, February 27, 2026 Life Science Investing
NeoGenomics Introduces PanTracer Pro to Support Timely, Informed Solid Tumor Therapy Selection Life Science Investing
Medexus Announces Fiscal Q3 2026 Results, Driven by Continued Strong Year-To-Date Product-Level Performance of GRAFAPEX for Injection Pharmaceutical Investing
InMed Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update Pharmaceutical Investing
